Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease

Annals of the Rheumatic Diseases

Volumn 55, Issue 2, 1996, Pages 128-133

  Sahin S ^a   Akoglu T ^a,b   Direskeneli, H ^a   Sen L S ^a   Lawrence, R ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Marmara Universite Hastanesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TUMOR NECROSIS FACTOR;

ARTICLE; BEHCET DISEASE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD11; ANTIGENS, CD18; BEHCET SYNDROME; CELL ADHESION; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; NEUTROPHIL ACTIVATION; NEUTROPHILS;

EID: 0030048813     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.2.128     Document Type: Article

References (22)

1. Mizushima Y. Chemotaxis and phagocytosis of Leukocytes in Behçet's disease: an overview. In: Lehner T, Barnes C G, eds. Recent advances in Behçet's disease. London: Royal Society of Medicine Services, 1986; 85-7.
2. Efthimiou B V, Johnson E, Addison E. In vivo leucocyte migration in Behçet's syndrome. In: Lehner T, Barnes C G, eds. Recent advances in Behçet's disease. London: Royal Society of Medicine Services 1986; 99.
3. Takeuchi A, Kobayashi M, Mori M, Mizushima Y. Neutrophil function in patients with Behçet's disease. In: Inaba G, ed. Behçet's disease. Tokyo: University of Tokyo Press, 1982; 251-8.
4. Kasukawa R, Miyata M, Takeda N, Nishimaki T, Ohara M, Yoshida H. Studies on phagocytosis of PMN of patients with Behçet's disease. In: Inaba G, ed. Behçet's disease. Tokyo: University of Tokyo Press, 1982; 269-77.
5. Masuda K, Namba K. Lysosomal enzymes in leucocytes from patients with Behçet's disease. In: Inaba G, ed. Behçet's disease. Tokyo: University of Tokyo Press, 1982; 259-67.
6. Kansu E, Sivri B, Sahin G, et al. Endothelial cell dysfunction in Behçet's disease. In: O'Duffy J D, Kökmen E, eds. Behçet's disease. New York: Marcel Dekker Inc, 1991; 523-30.
7. Akoǧlu T F, Direskeneli H, Yazici H, Lawrence R. TNF, soluble IL-2R and soluble CD8 in Behçet's disease. J Rheumatol 1990; 17: 1107-8.
8. Mege J L, Dilşen N, Sanguedolce V, et al. Overproduction of monocytes derived tumor necrosis factor, IL-6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. J Rheumatol 1993; 20: 1544-9.
9. Memişoǧlu H, Aksu H S Z, Erken E, Göcük M, Serum interleukin-1 level in Behçet's disease. In: O'Duffy J D, Kökmen E, eds. Behçet's disease. New York: Marcel Dekker Inc, 1991; 387-91.
10. International study group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
11. Ferrante A, Thong Y H. A rapid one step procedure for purification of mononuclear and polymorphonuclear leucocytes from human blood using modification of the hypaque-ficoll technique. J Immunol Methods 1978; 24: 389-93.
12. Gamble J R, Harlan J M, Klebanoff S J, Vadas M A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82: 8667-71.
13. Jaffe E A, Nachman R L, Beacker C G, Minick R. Culture of human endothelial cells derived from umblical veins. J Clin Invest 1973; 52: 2745-56.
14. Vennegoor C J G M, Kemenade E W, Huijbens R J F, Sanches-Madrid F, Melief C J M, Figdor C G. Role of LFA-1 and VLA-4 in the adhesion of cloned normal and LFA-1 (CD11/CD18) deficient T cells to cultured endothelial cells. J Immunol 1992; 148: 1093-101.
15. Dinehart S, Jorizzo J L. Immunology: neutrophil, circulating immune complexes, complement. In: Plotkin G R, Calabro J J, O'Duffy J D, eds. Behçet's disease: a contemporary synopsis. Mount Kisko; Futura Publishing Co Inc, 1983; 63-71.
16. Jorizzo J L, Solomon A R, Cavallo T. Behçet syndrome: immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 1985; 109: 747-51.
17. Williams B D, Lehner T. Immune complexes in Behçet's syndrome and recurrent oral ulceration. BMJ 1977; i: 1387-9.
18. Jorizzo J L, Schmalstieg F C, Solomon A R, Taylor R S, Carallo T, Studies of circulating immune complexes, neutrophils and effects of oral colchicine or thalidomide in Behçet's discase. In: Lehner T, Barnes C G, eds. Recent advances in Behçet's disease. London: Royal Society of Medicine Services, 1985; 89-96.
19. Hirohata S, Takeuchi A, Miyomato T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with neuro-Behçet's disease. In: O'Duffy J D, Kökmen E, eds. Behçet's disease. New York: Marcel Dekker Inc, 1991; 369-76.
20. Zimmerman G A, Prescott S M, McIntyre T M. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 1992; 13: 93-100.
21. Hetchman D H, Cyhulsky M I, Fuchs J H, Baker J B, Gimbrone M A. Intravascular IL-8. J Immunol 1991; 147: 883-92.
22. Danner R L, Suffredini A F, Vandervort A L, et al. Detection of IL-6 and IL-8 during septic shock in humans. Clin Res 1990; 38: 352-A.